| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.700 | None | 0.984 | 123 | 7 | 1998 | 2020 | ||||||||
|
heme oxygenase 1 | 0.381 | 0.923 | 9.7E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
platelet derived growth factor receptor alpha | 0.415 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2004 | 2018 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2003 | 2019 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 2003 | 2019 | ||||||||
|
factor interacting with PAPOLA and CPSF1 | 0.575 | 0.577 | 0.79 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2004 | 2012 | ||||||||
|
fms related receptor tyrosine kinase 3 | 0.462 | 0.654 | 0.61 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2003 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2009 | 2016 | ||||||||
|
TNF receptor superfamily member 8 | 0.444 | 0.808 | 0.86 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 2010 | 2019 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
CD34 molecule | 0.368 | 0.808 | 5.0E-06 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2006 | 2018 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 2005 | 2014 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2007 | 2018 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2007 | 2018 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2007 | 2018 | ||||||||
|
ASXL transcriptional regulator 1 | 0.482 | 0.808 | 1.3E-14 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2018 | ||||||||
|
ectonucleotide pyrophosphatase/phosphodiesterase 3 | 0.663 | 0.538 | 3.5E-23 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2009 | 2019 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2016 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2009 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2015 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2016 | ||||||||
|
sphingomyelin phosphodiesterase 1 | 0.499 | 0.885 | 3.9E-10 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2016 | ||||||||
|
C-type lectin domain family 4 member D | 0.587 | 0.538 | 2.5E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2006 | 2014 | ||||||||
|
RUNX1 partner transcriptional co-repressor 1 | 0.530 | 0.808 | 0.98 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2007 | 2012 |